Interactions of human immunodeficiency virus-1 proteins with neurons: Possible role in the development of human immunodeficiency virus-1-associated dementia

European Journal of Clinical Investigation

Volumn 32, Issue 8, 2002, Pages 619-627

  Van De Bovenkamp, M ^a   Nottet, H S L M ^a   Pereira, Cândida Da Fonseca ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Acquired immunodeficiency; Human immunodeficiency virus 1 proteins; Human immunodeficiency virus 1 associated dementia; Neurons; Neurotoxicity

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; NEF PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN; VPR PROTEIN; VPU PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN; DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; NERVE CELL; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW;

AIDS DEMENTIA COMPLEX; GENE PRODUCTS, NEF; GENE PRODUCTS, REV; GENE PRODUCTS, TAT; GENE PRODUCTS, VPR; GENE PRODUCTS, VPU; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; NEURONS;

EID: 0037000758     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.01029.x     Document Type: Review

References (93)

1. Nottet HSLM, Gendelman HE. Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol Today 1995;16:441-8.
2. Nottet HSLM. Interactions between macrophages and brain microvascular endothelial cells: role in pathogenesis of HIV-1 infection and blood-brain barrier function. J Neurovirol 1999;5:659-69.
3. McArthur JC, Sacktor N, Selnes OA. Human immunodeficiency virus-associated dementia. Semin Neurol 1999;19:129-50.
4. Price RW, Brew BJ, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239:586-92.
5. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19:517-24.
6. Bindels PJ, Poos RMJ, Tong JT, Mulder JW, Jager HJC, Coutinho RA. Trends in mortality among AIDS patients in Amsterdam 1982-1988. AIDS 1991;5:853-8.
7. Portegies P, Enting RH, de Gans J, Algra PR, Derix MMA, Lange JMA et al. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, the Netherlands. AIDS 1993;7:669-75.
8. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 1995;38:563-70.
9. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986;83:7089-93.
10. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R et al. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 1996;10:573-85.
11. Nottet HSLM, Bar DR, van Hassel H, Verhoef J, Boven LA. Cellular aspects of HIV-1 infection of macrophages leading to neuronal dysfunction in in vitro models for HIV-1 encephalitis. J Leukoc Biol 1997;62:107-16.
12. Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 1999;13:1-22.
13. Nottet HSLM, Jett M, Flanagan CR, Zhai Q-H, Persidsky Y, Rizzino A et al. A regulatory role for astrocytes in HIV-1 encephalitis. J Immunol 1995;154:3567-81.
14. Esiri MM, Morris CS, Millard PR. Fate of oligodendrocytes in HIV-1 infection. AIDS 1991;5:1081-8.
15. Nath A, Haughley NJ, Jones M, Anderson C, Bell JE, Geiger JD. Synergisitic neurotoxicity by human immunodeficiency virus proteins tat and gp120: protection by memantine. Ann Neurol 2000;47:186-94.
16. Caffrey M, Braddock DT, Louis JM, Abu-Asab MA, Kingma D, Liotta L et al. Biophysical characterization of gp41 aggregates suggests a model for the molecular mechanism of HIV-associated neurological damage and dementia. J Biol Chem 2000;275:19877-82.
17. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990;345:84-6.
18. Guy B, Riviere Y, Dott K, Regnault A, Kieny MP. Mutational analysis of the HIV nef protein. Virology 1990;176:413-25.
19. Levy DN, Refaeli Y, MacGregor RR, Weiner DB. Serum vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1994;91:10873-7.
20. Weclewiczs K, Ekstrom M, Kristensson K, Garoff H. Specific interactions between retrovirus env and gag proteins in rat neurons. J Virol 1998;72:2832-45.
21. Jones IM, Morikawa Y. The molecular basis of HIV capsid assembly. Rev Med Virol 1998;8:87-95.
22. Nath A, Geiger J. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog Neurobiol 1998;54:19-33.
23. Boven LA, Middel J, Verhoef J, De Groot CJA, Nottet HSLM. Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1 associated dementia. Neuropath Appl Neurobiol 2000;26:356-60.
24. Freed EO. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 1998;251:1-15.
25. Hill CM, Deng H, Unutmaz D, Kewalramani VN, Bastiani L, Gorny MK et al. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry ancd make direct CD4-dependent interactions with this chemokine receptor. J Virol 1997;71:6296-304.
26. Xiong H, Zeng Y-C, Lewis T, Zheng J, Persidsky Y, Gendelman HE. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1 associated dementia. J Neurovirol 2000;suppl.1:S14-23.
27. Kandel ER, Schwartz JH. Directly gated transmission at central synapses. In: Kandel ER, Schwartz JH, Jessell TM, editors. Principles of neural science. Connecticut: Appleton and Lange;1991.pp. 153-72.
28. Kaul M, Lipton SA. The NMDA receptor - its role in neuronal apoptosis and HIV-associated dementia. NeuroAIDS 2000;3:www.sciencemag.org/NAIDS.
29. Pattarini R, Pittaluga A, Raiteri M. The human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-D-aspartate receptors mediating noradrenaline release in the hippocampus. Neuroscience 1998;87:147-57.
30. Pittaluga A, Pattarini R, Severi P, Raiteri M. Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120. AIDS 1996;10:463-8.
31. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991;7:111-18.
32. Meucci O, Miller RJ. gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-β1. J Neurosci 1996;16:4080-8.
33. Wu P, Price P, Du B, Hatch WC, Terwilliger EF. Direct cytotoxicity of HIV-1 envelope protein gp120 on human NT neurons. Neuroreport 1996;7:1045-9.
34. Savio T, Levi G. Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C. a study with rat cerebellar granule cell cultures. J Neurosci Res 1993;34:265-72.
35. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 1990;248:364-7.
36. Gemignani A, Paudice P, Pittaluga A, Raiteri M. The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release. J Neurosci 2000;12:2839-46.
37. Paudice P, Gemignani A, Raiteri M. Evidence for functional native NMDA receptors activated by glycine or D-serine alone in the absence of glutamatergic coagonist. Eur J Neurosci 1998;10:2934-44.
38. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV- associated dementia. Nature 2001;410:988-94.
39. Gutkind JS. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 1998;273:1839-42.
40. Lazarini F, Casanova P, Tham TN, De Clerq E, Arenzana-Seisdedos F, Baleux F et al. Differential signalling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes. Eur J Neurosci 2000;12:117-25.
41. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ. Chemokines regulate hippocampal neuronal signalling and gp120 neurotoxicity. Proc Natl Acad Sci USA 1998;95:14500-5.
42. Meucci O, Fatatis A, Simen AA, Miller RJ. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA 2000;97:8075-80.
43. Van der Meer P, Ulrich A, Gonzalez Scarano F, Lavi E. Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. Exp Mol Pathol 2000;69:192-201.
44. Hesselgesser J, Taub D, Baskar P, Greenberg M, Hoxie J, Kolson DL et al. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1a is mediated by the chemokine receptor CXCR4. Curr Biol 1998;8:595-8.
45. Davis CB, Dikic I, Unutmaz D, Hill CM, Arthos J, Siani MA et al. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 1997;186:1793-8.
46. Hesselgesser J, Halks-Miller M, Delvecchio V, Peiper SC, Hoxie J, Kolson DL. CD4 independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr Biol 1997;7:112-21.
47. Obata T, Brown GE, Yaffe MB. MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit Care Med 2000;28:N67-77.
48. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-31.
49. Lannuzel A, Barnier JV, Hery C, Tan HV, Guibert B, Gray F et al. Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann Neurol 1997;42:847-56.
50. Ganju RK, Dutt P, Wu L, Newman W, Avraham H, Avraham S et al. β-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK. Blood 1998;91:791-7.
51. 2+-induced regulation of ion channel and MAP kinase functions. Nature 1995;376:737-45.
52. Catani M, Corasaniti M, Navarra M, Nistico G, Finazzi Agro A, Melino G. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. J Neurochem 2000;74:2373-9.
53. Pandey V, Bolsover S. Immediate and neurotoxic effects of HIV protein gp120 act through CXCR4 receptor. Biochem Biophys Res Commun 2000;274:212-15.
54. Bruno V, Copani A, Besong G, Scoto G, Nicoletti F. Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture. Eur J Pharmacol 2000;399:117-21.
55. Galasso JM, Harrison JK, Silverstein FS. Excitotoxic brain injury stimulates expression of the chemokine receptor CCR5 in neonatal rats. Am J Pathol 1998;153:1631-40.
56. Luciw PA. Human Immunodeficiency Viruses and their replication. In: Fields BN, Knipe DM, Howley PM, editors. Virology. Philadelphia: Lippincott-Raven Publishers;1996.pp. 1881-952.
57. Moore JP, McKeating JA, Weiss RA, Sattentau QJ. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 1990;250:1139-42.
58. McKeating JA, McKnight A, Moore JP. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization. J Virol 1991;65:852-60.
59. Kure K, Weidenheim KM, Lyman WD, Dickson DW. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encepalitis. Acta Neuropathol 1990;80:393-400.
60. Chong YH, Seoh JY, Park HK. Increased activity of matrix metalloproteinase-2 in human glial and neuronal cell lines treated with HIV-1 gp41 peptides. J Mol Neurosci 1998;10:129-41.
61. Orsini MJ, Debouck CJ, Webb CL, Lysko PG. Extracellular human immunodeficiency virus type 1 tat protein promotes aggregation and adhesion of cerebellar neurons. J Neurosci 1996;16:2546-52.
62. Trono D. HIV accessory proteins: leading role for the supporting cast. Cell 1995;82:189-92.
63. Patel CA, Mukhtar M, Pomerantz RJ. Human immunodeficiency virus type 1 vpr induces apoptosis in human neuronal cells. J Virol 2000;74:9717-26.
64. Nijhawan D, Honarpour N, Wang X. Apoptosis in neuronal development and disease. Annu Rev Neurosci 2000;23:73-87.
65. Allsopp TE, Fazakerley JK. Altruistic cell suicide and the specialized case of the virus-infected nervous system. Trends Neurosci 2000;23:284-90.
66. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-16.
67. Piller SC, Ewart GD, Jans DA, Gage PW, Cox GB. The amino-terminal region of vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons. J Virol 1999;73:4230-8.
68. Piller SC, Jans P, Gage PW, Jans DA. Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. Proc Natl Acad Sci USA 1998;95:4595-600.
69. Roebuck KA, Saifuddin M. Regulation of HIV-1 transcription. Gene Expr 1999;8:67-84.
70. Ma M, Nath A. Molecular determinants for cellular uptake of tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 1997;71:2495-9.
71. 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells. J Neurosci 1994;14:187-97.
72. Schwartz J, Kandel ER. Synaptic transmission mediated by second messengers. In: Kandel ER, Schwartz JH, Jessell TM, editors. Principles of Neural Science. Connecticut: Appleton and Lange;1991.pp. 173-93.
73. Nath A, Psooy K, Martin C, Knudsen B, Magnuson DSK, Haughey N et al. Identification of a human immunodeficiency virus type 1 tat epitope that is neuroexcitatory and neurotoxic. J Virol 1996;70:1475-80.
74. Magnuson DSK, Knudsen BE, Geiger JD, Brownstone RM, Nath A. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 1995;37:373-80.
75. New DR, Maggirwar SB, Epstein LG, Dewhurst S, Gelbard HA. HIV-1 tat induces neuronal death via tumor necrosis factor-α and activation of non-N-methyl-D-aspartate receptors by a NFkB-independent mechanism. J Biol Chem 1998;273:17852-8.
76. Cheng J, Nath A, Knudsen BE, Hochman S, Geiger JD, Ma M et al. Neuronal excitatory properties of human immunodeficiency virus type 1 tat protein. Neuroscience 1998;82:97-106.
77. Kruman II, Nath A, Mattson MP. HIV-1 protein tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 1998;154:276-88.
78. Menegon A, Leoni C, Benfenati F, Valtorta F. Tat protein form HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum. Biol Biophys Res Comm 1997;238:800-5.
79. FAK and its association with phosphoinositide 3-kinase in PC12 cells. AIDS 1998;12:1275-84.
80. FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell 1992;71:891-4.
81. Milani D, Mazzoni M, Borgatti P, Zauli G, Cantley L, Capitani S. Extracellular human immunodeficiency virus type-1 tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells. J Biol Chem 1996;271:22961-4.
82. Maggirwar SB, Tong N, Ramirez S, Gelbard HA, Dewhurst S. HIV-1 tat-mediated activation of glycogen synthase kinase-3β contributes to tat-mediated neurotoxicity. J Neurochem 1999;73:578-86.
83. Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995;267:2003-6.
84. Zauli G, Gibellini D, Milani D, Mazzoni M, Borgatti P, La Placa M et al. Human immunodeficiency virus type 1 tat protein protects lymphoid, epithelial and neuronal cell lines from death by apoptosis. Cancer Res 1993;53:4481-5.
85. Zauli G, La Placa M, Vignoli M, Re MC, Gibellini D, Furlini G et al. An autocrine loop of HIV type-1 tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. J AIDS 1995;10:306-16.
86. Pollard VW, Malim MH. The HIV-1 rev protein. Annu Rev Microbiol 1998;52:491-532.
87. Mabrouk K, Van Rietschoten J, Vives E, Darbon H, Rochat H, Sabatier JM. Lethal neurotoxicity in mice of the basic domains of HIV and SIV rev proteins. Study of these regions by circular dichroism. FEBS Lett 1991;289:13-17.
88. Ewart GD, Sutherland T, Gage PW, Cox GB. The vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J Virol 1996;70:7108-15.
89. Gonzalez ME, Carrasco L. The human immunodeficiency virus type 1 vpu protein enhances membrane permeability. Biochemistry 1998;37:13710-19.
90. Curtain CC, Separovic F, Rivett D, Kirkpatrick A, Waring AJ, Gordon LM et al. Fusogenic activity of amino-terminal region HIV type 1 nef protein. AIDS Res Hum Retroviruses 1994;10:1231-40.
91. Otake K, Fujii Y, Nakaya T, Nishino Y, Zhong Q, Fujinaga K et al. The carboxyl-terminal region of HIV-1 nef protein is a cell surface domain that can interact with CD4+ T cells. J Immunol 1994;153:5826-37.
92. Trillo-Pazos G, McFarlane-Abdulla E, Campbell IC, Pilkington GJ, Everall IP. Recombinant nef HIV-IIIB protein is toxic to human neurons in culture. Brain Res 2000;864:315-26.
93. + channels. AIDS 1991;5:1301-8.